MRNA – Moderna, Inc.
Moderna, Inc.MRNA
$248.69Name : Moderna, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $100,625,186,816.00
EPSttm : -7.04
Moderna, Inc.
$248.69
0.85%$2.14
MRNA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
8.93
Margin Of Safety %
Put/Call OI Ratio
1.53
EPS Next Q Diff
-2.23
EPS Last/This Y
-1.47
EPS This/Next Y
3.92
Price
250.74
Target Price
155.95
Analyst Recom
3.07
Performance Q
293.95
Upside
-198.9%
Beta
1.14
Ticker: MRNA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | MRNA | 213.72 | 1.39 | 1.10 | 829020 |
| 2026-10-13 | MRNA | 214.76 | 1.39 | 0.76 | 855038 |
| 2026-10-14 | MRNA | 226.3 | 1.37 | 0.83 | 871520 |
| 2026-10-15 | MRNA | 236.47 | 1.39 | 0.68 | 890524 |
| 2026-10-16 | MRNA | 217.08 | 1.40 | 0.89 | 924030 |
| 2026-10-19 | MRNA | 226.81 | 1.39 | 0.94 | 788865 |
| 2026-10-20 | MRNA | 242.14 | 1.41 | 1.10 | 811785 |
| 2026-10-21 | MRNA | 246.02 | 1.44 | 1.15 | 841277 |
| 2026-10-22 | MRNA | 202.63 | 1.48 | 1.49 | 871644 |
| 2026-10-23 | MRNA | 199.8 | 1.45 | 1.16 | 935634 |
| 2026-10-26 | MRNA | 198.31 | 1.45 | 1.22 | 853605 |
| 2026-10-27 | MRNA | 207.97 | 1.43 | 1.16 | 867435 |
| 2026-10-28 | MRNA | 214.28 | 1.44 | 0.69 | 885654 |
| 2026-10-29 | MRNA | 222.76 | 1.41 | 0.73 | 907944 |
| 2026-10-30 | MRNA | 221.72 | 1.41 | 0.66 | 920251 |
| 2026-11-02 | MRNA | 220.88 | 1.43 | 1.05 | 806802 |
| 2026-11-03 | MRNA | 228.38 | 1.42 | 1.16 | 815736 |
| 2026-11-04 | MRNA | 258.25 | 1.44 | 1.03 | 829769 |
| 2026-11-05 | MRNA | 240.17 | 1.46 | 2.54 | 854765 |
| 2026-11-06 | MRNA | 253.07 | 1.51 | 0.66 | 890526 |
| 2026-11-09 | MRNA | 269 | 1.53 | 0.99 | 824318 |
| 2026-11-10 | MRNA | 251.22 | 1.53 | 1.41 | 846374 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | MRNA | 213.69 | -100.0 | - | -8.39 |
| 2026-10-13 | MRNA | 214.52 | -100.0 | - | -8.39 |
| 2026-10-14 | MRNA | 226.32 | -100.0 | - | -8.39 |
| 2026-10-15 | MRNA | 236.44 | -100.0 | - | -8.39 |
| 2026-10-16 | MRNA | 217.91 | -100.0 | - | -8.38 |
| 2026-10-19 | MRNA | 226.88 | -100.0 | - | -8.38 |
| 2026-10-20 | MRNA | 226.88 | -100.0 | - | -8.38 |
| 2026-10-21 | MRNA | 242.08 | -100.0 | - | -8.38 |
| 2026-10-22 | MRNA | 202.62 | -100.0 | - | -8.38 |
| 2026-10-23 | MRNA | 200.05 | -100.0 | - | -8.38 |
| 2026-10-26 | MRNA | 198.79 | -100.0 | - | -8.39 |
| 2026-10-27 | MRNA | 207.90 | -100.0 | - | -8.49 |
| 2026-10-28 | MRNA | 214.15 | -100.0 | - | -8.49 |
| 2026-10-29 | MRNA | 222.86 | -100.0 | - | -8.49 |
| 2026-10-30 | MRNA | 221.68 | -100.0 | - | -8.49 |
| 2026-11-02 | MRNA | 220.90 | -100.0 | - | -8.50 |
| 2026-11-03 | MRNA | 228.39 | -100.0 | - | -8.49 |
| 2026-11-04 | MRNA | 258.25 | -100.0 | - | -8.49 |
| 2026-11-05 | MRNA | 241.43 | -100.0 | - | -8.49 |
| 2026-11-06 | MRNA | 252.91 | -100.0 | - | -8.49 |
| 2026-11-09 | MRNA | 269.00 | -100.0 | - | -8.49 |
| 2026-11-10 | MRNA | 250.74 | -46.2 | - | -8.73 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | MRNA | -2.29 | 2.12 | 8.45 |
| 2026-10-13 | MRNA | -2.29 | 2.12 | 8.45 |
| 2026-10-14 | MRNA | -2.29 | 2.12 | 8.45 |
| 2026-10-15 | MRNA | -2.29 | 2.12 | 8.45 |
| 2026-10-16 | MRNA | -2.29 | 2.12 | 8.45 |
| 2026-10-19 | MRNA | -2.51 | 2.20 | 8.45 |
| 2026-10-20 | MRNA | -2.51 | 2.20 | 8.45 |
| 2026-10-21 | MRNA | -2.51 | 2.20 | 8.45 |
| 2026-10-22 | MRNA | -2.51 | 2.20 | 8.45 |
| 2026-10-23 | MRNA | -2.51 | 2.20 | 8.45 |
| 2026-10-26 | MRNA | -2.51 | 1.97 | 8.45 |
| 2026-10-27 | MRNA | -2.51 | 1.97 | 8.93 |
| 2026-10-28 | MRNA | -2.51 | 1.97 | 8.93 |
| 2026-10-29 | MRNA | -2.51 | 1.97 | 8.93 |
| 2026-10-30 | MRNA | -2.51 | 1.97 | 8.93 |
| 2026-11-02 | MRNA | -2.51 | 2.00 | 8.93 |
| 2026-11-03 | MRNA | -2.51 | 2.00 | 8.93 |
| 2026-11-05 | MRNA | -2.49 | 2.00 | 8.93 |
| 2026-11-06 | MRNA | -2.49 | 2.00 | 8.93 |
| 2026-11-09 | MRNA | -2.49 | 2.46 | 8.93 |
| 2026-11-10 | MRNA | -2.49 | 2.46 | 8.93 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.38
Avg. EPS Est. Current Quarter
-3.08
Avg. EPS Est. Next Quarter
-1.85
Insider Transactions
-2.49
Institutional Transactions
2.46
Beta
1.14
Average Sales Estimate Current Quarter
542
Average Sales Estimate Next Quarter
228
Fair Value
Quality Score
35
Growth Score
34
Sentiment Score
100
Actual DrawDown %
33.4
Max Drawdown 5-Year %
-93.9
Target Price
155.95
P/E
Forward P/E
PEG
P/S
40.19
P/B
14.82
P/Free Cash Flow
EPS
-7.09
Average EPS Est. Cur. Y
-8.73
EPS Next Y. (Est.)
-4.81
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-110.46
Relative Volume
0.51
Return on Equity vs Sector %
-67.1
Return on Equity vs Industry %
-47.4
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.35
EBIT Estimation
◆
MRNA
Healthcare
$250.83
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
59.7
Range 1M
70.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-6.8%
EPS NY
43.8%
52W%
88.6%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-37.8% upside
Upside
-37.8%
Quality
35
MRNA — P/E HistoricalBiotechnology
Moderna, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 4700
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
MRNA
Latest News
—
Caricamento notizie per MRNA…
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading